PT84537A - Process for the preparation of pharmaceutical compositions containing a proteinaceous material useful for the treatment of diabetes mellitus - Google Patents

Process for the preparation of pharmaceutical compositions containing a proteinaceous material useful for the treatment of diabetes mellitus

Info

Publication number: PT84537A
Authority: PT; Portugal
Prior art keywords: preparation; treatment; pharmaceutical compositions; compositions containing; diabetes mellitus
Prior art date: 1986-03-21

Application number

PT84537A

Other languages

English (en)

Inventor

Young W Cho

Original Assignee

Eurasiam Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-21

Filing date

1987-03-20

Publication date

1987-04-01

1987-03-20 Application filed by Eurasiam Lab filed Critical Eurasiam Lab

1987-04-01 Publication of PT84537A publication Critical patent/PT84537A/pt

Links

239000000463 material Substances 0.000 title abstract 4
206010012601 diabetes mellitus Diseases 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
102000004190 Enzymes Human genes 0.000 abstract 2
108090000790 Enzymes Proteins 0.000 abstract 2
239000011248 coating agent Substances 0.000 abstract 2
238000000576 coating method Methods 0.000 abstract 2
239000008177 pharmaceutical agent Substances 0.000 abstract 2
102000007330 LDL Lipoproteins Human genes 0.000 abstract 1
108010007622 LDL Lipoproteins Proteins 0.000 abstract 1
239000004599 antimicrobial Substances 0.000 abstract 1
239000011230 binding agent Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000003995 emulsifying agent Substances 0.000 abstract 1
230000001804 emulsifying effect Effects 0.000 abstract 1
239000002702 enteric coating Substances 0.000 abstract 1
238000009505 enteric coating Methods 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
230000002366 lipolytic effect Effects 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
230000000087 stabilizing effect Effects 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)

PT84537A 1986-03-21 1987-03-20 Process for the preparation of pharmaceutical compositions containing a proteinaceous material useful for the treatment of diabetes mellitus PT84537A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US84262586A	1986-03-21	1986-03-21

Publications (1)

Publication Number	Publication Date
PT84537A true PT84537A (en)	1987-04-01

Family

ID=25287846

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT84537A PT84537A (en)	1986-03-21	1987-03-20	Process for the preparation of pharmaceutical compositions containing a proteinaceous material useful for the treatment of diabetes mellitus

Country Status (16)

Country	Link
EP (1)	EP0302065B1 (pt)
JP (1)	JPH01500589A (pt)
KR (1)	KR900001074B1 (pt)
CN (1)	CN87103560A (pt)
AT (1)	ATE109659T1 (pt)
AU (1)	AU608756B2 (pt)
CA (1)	CA1281645C (pt)
DE (1)	DE3750369T2 (pt)
FI (1)	FI95538C (pt)
HK (1)	HK88696A (pt)
HU (1)	HU207452B (pt)
IE (1)	IE65667B1 (pt)
PT (1)	PT84537A (pt)
RU (1)	RU1814559C (pt)
WO (1)	WO1987005505A1 (pt)
ZA (1)	ZA872018B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI77573C (fi) *	1987-05-08	1989-04-10	Orion Yhtymae Oy	Ny konsistens.
FR2634376B1 (fr) *	1988-07-21	1992-04-17	Farmalyoc	Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
NZ230764A (en) *	1988-09-27	1991-01-29	Takeda Chemical Industries Ltd	Enteric films comprising hydroxypropylmethylcellulose phthalate, polyethylene glycol and shellac; preparation thereof
GB9007052D0 (en) *	1990-03-29	1990-05-30	Skua Investments Ltd	Pharmaceutical formulations
US5439967A (en) *	1991-09-17	1995-08-08	Micro Vesicular Systems, Inc.	Propylene glycol stearate vesicles
US5206219A (en) *	1991-11-25	1993-04-27	Applied Analytical Industries, Inc.	Oral compositions of proteinaceous medicaments
CN1228708A (zh) *	1996-09-04	1999-09-15	有限会社多特	经口给药用含肽药物组合物
JP2002525106A (ja)	1998-09-25	2002-08-13	グリコックスコーポレイションリミティド	フルクトサミンオキシダーゼアッセイ：方法及び材料
CN1324234A (zh)	1998-09-25	2001-11-28	格利科克斯有限公司	果糖胺氧化酶,拮抗剂和抑制剂
IL126447A (en) *	1998-10-04	2004-09-27	Vascular Biogenics Ltd	An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
WO2000022909A2 (en) *	1998-10-19	2000-04-27	Biotech Australia Pty. Limited	Systems for oral delivery
US6482811B1 (en)	1999-01-08	2002-11-19	Marvin B. Bacaner	Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions
US6884792B2 (en)	1999-01-08	2005-04-26	Marvin B. Bacaner	Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
CN1141974C (zh)	2000-06-07	2004-03-17	张昊	结肠定位释放的口服生物制剂
IT1319655B1 (it)	2000-11-15	2003-10-23	Eurand Int	Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
JP4592041B2 (ja) *	2000-11-24	2010-12-01	株式会社Ｎｒｌファーマ	生活の質を改善する新規食品の製造法および用途
US8658202B2 (en)	2001-04-25	2014-02-25	Western University Of Health Sciences	Coated drug delivery formulations
JP5595626B2 (ja) *	2001-06-22	2014-09-24	株式会社パウレック	コーティング装置
JP2003001090A (ja) *	2001-06-22	2003-01-07	Pauretsuku:Kk	流動層装置
US6837696B2 (en) *	2001-09-28	2005-01-04	Mcneil-Ppc, Inc.	Apparatus for manufacturing dosage forms
ES2386782T3 (es)	2002-03-08	2012-08-30	Philera New Zealand Limited	Prevención y/o tratamiento de la enfermedad cardiovascular y/o la insuficiencia cardíaca asociada
CA2875522A1 (en)	2002-08-20	2004-03-04	Philera New Zealand Limited	Dosage forms and related therapies
EP1778618B1 (en)	2004-07-19	2013-12-25	PhilERA New Zealand Limited	Synthesis of triethylenetetramines
AU2008218595B2 (en)	2007-02-20	2012-05-24	Allergan Therapeutics LLC	Stable digestive enzyme compositions
WO2009109856A2 (en)	2008-03-07	2009-09-11	Axcan Pharma Inc.	Method for detecting infectious parvovirus in pharmaceutical preparations
UA111726C2 (uk)	2010-10-01	2016-06-10	Апталіс Фарма Лімітед	Препарат панкреліпази низької сили з кишковорозчинним покриттям
MX351014B (es)	2011-08-08	2017-09-28	Aptalis Pharma Ltd	Metodo para la prueba de disolucion de composiciones solidas que contienen enzimas digestivas.
RU2519099C1 (ru) *	2012-11-08	2014-06-10	Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН)	Фармацевтическая композиция
US10184121B2 (en)	2013-06-28	2019-01-22	Allergan Pharmaceuticals International Limited	Methods for removing viral contaminants from pancreatic extracts
CN106163544A (zh)	2013-08-09	2016-11-23	阿勒根制药国际有限公司	适于经肠施用的消化酶组合物
JP7233852B2 (ja) *	2018-04-17	2023-03-07	キョーリンリメディオ株式会社	変色が抑制された固形製剤
WO2020026471A1 (ja) *	2018-07-31	2020-02-06	株式会社親広産業	グルコース消費促進剤および解糖系促進剤
WO2020026570A1 (ja) *	2018-07-31	2020-02-06	株式会社親広産業	グルコース消費促進剤および解糖系促進剤
JP6823212B1 (ja)	2020-01-31	2021-01-27	株式会社中田製作所	スクイズ装置
US20240366731A1 (en)	2021-08-12	2024-11-07	Celagenex Research (India) Pvt. Ltd.	Oral algal oil based gastro-intestinal tract permeable peptide composition
CN114313354B (zh) *	2021-12-29	2022-11-08	江南大学	一种基于红外加热的液体微胶囊固化装置及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1416304A (fr) *	1961-10-10	1965-11-05	Smith Kline French Lab	Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
GB1155036A (en) *	1966-07-08	1969-06-11	Ethan Allan Brown	Injectionable Substance
YU36434B (en) *	1969-05-14	1984-02-29	Sanol Arznei Schwarz Gmbh	Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US3922339A (en) *	1974-06-20	1975-11-25	Kv Pharm Co	Sustained release medicant
US4356167A (en) *	1978-01-27	1982-10-26	Sandoz, Inc.	Liposome drug delivery systems
US4173626A (en) *	1978-12-11	1979-11-06	Merck & Co., Inc.	Sustained release indomethacin
US4447412A (en) *	1983-02-01	1984-05-08	Bilton Gerald L	Enzyme-containing digestive aid compostions
IL68769A (en) *	1983-05-23	1986-02-28	Hadassah Med Org	Pharmaceutical compositions containing insulin for oral administration
JPS6058915A (ja) *	1983-09-12	1985-04-05	Fujisawa Pharmaceut Co Ltd	薬物含有脂質小胞体製剤
NZ210785A (en) *	1984-01-13	1987-11-27	Battelle Development Corp	Liquid dispersions of layered controlled release dosage forms

1987
- 1987-03-12 EP EP87902224A patent/EP0302065B1/en not_active Expired - Lifetime
- 1987-03-12 AT AT87902224T patent/ATE109659T1/de not_active IP Right Cessation
- 1987-03-12 JP JP62502136A patent/JPH01500589A/ja active Granted
- 1987-03-12 AU AU72073/87A patent/AU608756B2/en not_active Ceased
- 1987-03-12 DE DE3750369T patent/DE3750369T2/de not_active Expired - Fee Related
- 1987-03-12 HU HU871909A patent/HU207452B/hu not_active IP Right Cessation
- 1987-03-12 WO PCT/US1987/000485 patent/WO1987005505A1/en not_active Ceased
- 1987-03-16 IE IE69687A patent/IE65667B1/en not_active IP Right Cessation
- 1987-03-19 ZA ZA872018A patent/ZA872018B/xx unknown
- 1987-03-20 CA CA000532643A patent/CA1281645C/en not_active Expired - Fee Related
- 1987-03-20 CN CN198787103560A patent/CN87103560A/zh active Pending
- 1987-03-20 PT PT84537A patent/PT84537A/pt unknown
- 1987-03-20 KR KR1019870002612A patent/KR900001074B1/ko not_active Expired
1988
- 1988-09-19 FI FI884291A patent/FI95538C/fi not_active IP Right Cessation
- 1988-09-20 RU SU884356578A patent/RU1814559C/ru active
1996
- 1996-05-23 HK HK88696A patent/HK88696A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0302065A1 (en)	1989-02-08
JPH01500589A (ja)	1989-03-01
AU7207387A (en)	1987-10-09
KR870008587A (ko)	1987-10-19
JPH0576928B2 (pt)	1993-10-25
EP0302065A4 (en)	1990-09-12
HUT48821A (en)	1989-07-28
HK88696A (en)	1996-05-31
RU1814559C (ru)	1993-05-07
IE870696L (en)	1987-09-21
HU207452B (en)	1993-04-28
CN87103560A (zh)	1988-05-18
AU608756B2 (en)	1991-04-18
EP0302065B1 (en)	1994-08-10
ZA872018B (en)	1988-02-24
FI95538B (fi)	1995-11-15
DE3750369D1 (de)	1994-09-15
FI95538C (fi)	1996-02-26
CA1281645C (en)	1991-03-19
KR900001074B1 (ko)	1990-02-26
IE65667B1 (en)	1995-11-15
ATE109659T1 (de)	1994-08-15
FI884291L (fi)	1988-09-19
FI884291A0 (fi)	1988-09-19
DE3750369T2 (de)	1995-05-24
WO1987005505A1 (en)	1987-09-24

Publication	Publication Date	Title
HUT48821A (en)	1989-07-28	Process for production of medical compositions
US5719122A (en)	1998-02-17	Pharmaceutical compositions containing a calcitonin
EP0391369A3 (en)	1991-04-24	Medicinal emulsions
CA2330500A1 (fr)	1999-11-11	Compositions pharmaceutiques gelifiables
TNSN99224A1 (fr)	2005-11-10	Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
ATE91894T1 (de)	1993-08-15	Arzneizubereitungen zur transdermalen verabreichung von wirkstoffen.
IL115920A (en)	2003-11-23	PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION
JPS5513275A (en)	1980-01-30	Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it
EP1118326A3 (en)	2002-07-31	Reduction of liposome-induced adverse physiological reactions
IE791806L (en)	1980-03-25	Gastroprotective mollusc extract
EP0173664A3 (en)	1986-04-16	Biologically active benzimidazole compounds and process for their preparation
DE60031307D1 (de)	2006-11-23	Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen
GR920300128T1 (en)	1993-03-16	Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance
EP0652755A1 (en)	1995-05-17	THERAPEUTIC USE OF PHOSPHORYL-L-SERINE-N-ACYL-SPHINGOSINE.
ZA903111B (en)	1991-12-24	2-hydroxy-3-phenoxypropylamino compounds and pharmaceutical compositions containing them
BG44708A3 (bg)	1989-01-16	Метод за получаване на спиро-3-хетероазолони
Miura et al.	1982	Changes in intestinal alkaline phosphatase activity in cholera toxin-treated rats.
EP0335446A3 (en)	1991-04-03	Agents for treating neoplasms
EP0348664A3 (en)	1990-11-07	Pharmaceutical compositions containing monoacetoacetins for treating tumours
EP0210703A3 (en)	1987-05-13	Acylphosphorotriamides useful as lipid-altering agents
NO894083D0 (no)	1989-10-12	Framsoeytiske blandinger for behandling av adrenoleukodystrophy.
IE890275L (en)	1989-07-29	Pharmaceutical composition for 4-aroylimidazol-2-ones
JPS5592321A (en)	1980-07-12	Antilipemic agent
HUT49621A (en)	1989-10-30	Insecticides comprising thionophosphoric acid ester as active ingredient and process for producting the active ingredients
IE38967B1 (en)	1978-07-05	16-cyano-pregnene compounds